Such a phenomenon has been reported for leukaemias, where CXCL13-expressing malignant B cells showed an increased resistance against TNF-α-mediated apoptosis (Qiuping et al, 2005; Chunsong et al, 2006). Here, CXCL13 is linked to leukemia.